Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Approval

These articles are all highly relevant Approval. I believe this information can help you understand Approval's professional information. If you want to know more, you can contact us at any time, we can provide you with more professional guidance.
  • Tirzepatide Approved by NMPA for Type II Diabetes

    Tirzepatide Approved by NMPA for Type II Diabetes

    2024-05-21

    On May 21st, the Chinese National Medical Products Administration (NMPA) approved Tirzepatide (brand name Mounjaro), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Lilly, for the improvement of glycemic control in adults wi Read More